Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening.
This population-based study from Scotland evaluates the long-term effectiveness of the bivalent HPV vaccine administered...
Impact of health education on knowledge and perception of cervical cancer and screening among rural women in Bangladesh.
- Post category:Gynecologic Cancer
- Reading time:1 min read
This quasi-experimental study conducted in rural Tangail District, Bangladesh, evaluated the impact of a health educatio...
The Impact of Antiretroviral Therapy (ART) on HPV Persistence and Cervical Cancer Progression Among Women with HPV/HIV Co-infection: A Systematic Review.
- Post category:Gynecologic Cancer
- Reading time:1 min read
This systematic review evaluates the impact of antiretroviral therapy (ART) on the persistence of high-risk human papill...
Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18-gene panel.
- Post category:Gynecologic Cancer
- Reading time:1 min read
This study prospectively evaluated a tumor-first multigene next-generation sequencing (NGS) approach in epithelial ovari...
Health System Strategies to Improve the Uptake of Cervical Cancer Screening in Sub-Saharan Africa: A Scoping Systematic Review.
- Post category:Gynecologic Cancer
- Reading time:1 min read
This scoping systematic review examined health system-level strategies to overcome barriers to cervical cancer screening...
Germline Testing: The Therapeutic Biomarker You Can’t Afford to Miss
- Post category:Breast Cancer/Digestive (CRC, Stomach) System/Genitourinary (Prostate, Bladder) System/Gynecologic Cancer/Melanoma/Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
You may already be ordering germline testing at rates well above the national average — but across the U.S., most eligible patients still aren’t tested: Ovarian cancer: ~39% receive germline…